Difficulty: Medium
Average Score: 75%
Practice
Which antiemetic selectively blocks levodopa induced vomiting without blocking its antiparkinsonian action?
Correct answer
C
Rationale
In this scenario, the correct answer is option C) Domperidone. Domperidone is a peripherally acting dopamine receptor antagonist that selectively blocks levodopa-induced vomiting without interfering with its antiparkinsonian effects. This is because Domperidone does not readily cross the blood-brain barrier, allowing it to target the peripheral dopamine receptors in the gastrointestinal tract without affecting central dopamine receptors responsible for the antiparkinsonian action of levodopa.
Now let's analyze why the other options are incorrect:
A) Metoclopramide: While Metoclopramide is an antiemetic that acts by blocking dopamine receptors, it does not selectively target levodopa-induced vomiting. It can potentially interfere with levodopa's antiparkinsonian effects due to its ability to cross the blood-brain barrier.
B) Cisapride: Cisapride is a prokinetic agent that acts on serotonin receptors in the gut to enhance motility. It does not have a selective action on levodopa-induced vomiting.
D) Ondansetron: Ondansetron is a serotonin 5-HT3 receptor antagonist commonly used as an antiemetic for chemotherapy-induced nausea and vomiting. It does not selectively block levodopa-induced vomiting.
Educationally, understanding the specific mechanisms of action of different antiemetic drugs is crucial for healthcare professionals, especially when managing patients with complex conditions like Parkinson's disease. Knowing the pharmacological profiles of these medications helps in making informed decisions regarding their use to optimize patient outcomes and minimize adverse effects.
Now let's analyze why the other options are incorrect:
A) Metoclopramide: While Metoclopramide is an antiemetic that acts by blocking dopamine receptors, it does not selectively target levodopa-induced vomiting. It can potentially interfere with levodopa's antiparkinsonian effects due to its ability to cross the blood-brain barrier.
B) Cisapride: Cisapride is a prokinetic agent that acts on serotonin receptors in the gut to enhance motility. It does not have a selective action on levodopa-induced vomiting.
D) Ondansetron: Ondansetron is a serotonin 5-HT3 receptor antagonist commonly used as an antiemetic for chemotherapy-induced nausea and vomiting. It does not selectively block levodopa-induced vomiting.
Educationally, understanding the specific mechanisms of action of different antiemetic drugs is crucial for healthcare professionals, especially when managing patients with complex conditions like Parkinson's disease. Knowing the pharmacological profiles of these medications helps in making informed decisions regarding their use to optimize patient outcomes and minimize adverse effects.